Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The perils of surrogate endpoints.

Literature DB >> 25975658

The perils of surrogate endpoints.

William S Weintraub¹, Thomas F Lüscher², Stuart Pocock³.

Abstract

Mesh：

Substances：

Year: 2015 PMID： 25975658 PMCID： PMC4554958 DOI： 10.1093/eurheartj/ehv164

Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983

× No keyword cloud information.

68 in total

Review 1. Inotropic therapy for heart failure: an evidence-based approach.

Authors: G M Felker; C M O'Connor
Journal: Am Heart J Date: 2001-09 Impact factor: 4.749

2. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors: Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal: N Engl J Med Date: 2013-09-02 Impact factor: 91.245

Review 3. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.

Authors: Laura Mauri; E John Orav; Susana C Candia; Donald E Cutlip; Richard E Kuntz
Journal: Circulation Date: 2005-11-01 Impact factor: 29.690

4. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.

Authors: Stephan Fichtlscherer; Caroline Schmidt-Lucke; Susanne Bojunga; Lothar Rössig; Christopher Heeschen; Stefanie Dimmeler; Andreas M Zeiher
Journal: Eur Heart J Date: 2006-04-18 Impact factor: 29.983

5. The bumpy road to evidence: why many research findings are lost in translation.

Authors: Thomas F Lüscher
Journal: Eur Heart J Date: 2013-10-02 Impact factor: 29.983

6. In search of the right word: a statement of the HEART Group on scientific language.

Authors: Thomas F Lüscher
Journal: Eur Heart J Date: 2013-01 Impact factor: 29.983

Review 7. Imaging of coronary atherosclerosis by computed tomography.

Authors: Stephan Achenbach; Paolo Raggi
Journal: Eur Heart J Date: 2010-05-19 Impact factor: 29.983

8. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors: William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal: N Engl J Med Date: 2011-11-15 Impact factor: 91.245

9. Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245

10. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal: Eur Heart J Date: 2013-06-14 Impact factor: 29.983

14 in total

Review 1. Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors: Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal: J Cyst Fibros Date: 2016-12-28 Impact factor: 5.482

Review 2. Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice.

Authors: William B Mattes; Federico Goodsaid
Journal: Exp Biol Med (Maywood) Date: 2017-11-07

3. Perspective on Trends in Statin Use.

Authors: William S Weintraub
Journal: JAMA Cardiol Date: 2017-01-01 Impact factor: 14.676

4. The role of manual aspiration thrombectomy in the management of STEMI: a TOTALly different TASTE of TAPAS.

Authors: Goran Stankovic; Dejan Milasinovic
Journal: Postepy Kardiol Interwencyjnej Date: 2016-02-11 Impact factor: 1.426

Review 5. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?

Authors: Paul Welsh; Gianluca Grassia; Shani Botha; Naveed Sattar; Pasquale Maffia
Journal: Br J Pharmacol Date: 2017-06-10 Impact factor: 8.739

6. Warning About Shortcuts in Drug Development.

Authors: Robert M Califf
Journal: J Am Heart Assoc Date: 2017-03-21 Impact factor: 5.501

7. Evaluation at scale of microbiome-derived metabolites as biomarker of flavan-3-ol intake in epidemiological studies.

Authors: Javier I Ottaviani; Redmond Fong; Jennifer Kimball; Jodi L Ensunsa; Abigail Britten; Debora Lucarelli; Robert Luben; Philip B Grace; Deborah H Mawson; Amy Tym; Antonia Wierzbicki; Kay-Tee Khaw; Hagen Schroeter; Gunter G C Kuhnle
Journal: Sci Rep Date: 2018-06-29 Impact factor: 4.379